Pfizer

Company PFE

Last mentioned: 5h ago

Stories mentioning Pfizer 2

Earnings Neutral

Biotech Earnings: Tarsus and ORIC Signal Growth Amid Clinical Milestones

Tarsus Pharmaceuticals and ORIC Pharmaceuticals reported fourth-quarter 2025 results, highlighting a pivotal shift toward commercial scaling and clinical data maturation. While Tarsus focuses on the rapid adoption of XDEMVY, ORIC is advancing its oncology pipeline with key data readouts expected in 2026.

2 sources
Markets Neutral

Pharma's 'Netflix' Pivot: Solving the Antibiotic Market Failure

Health experts and economists are advocating for a subscription-based 'Netflix' model for antibiotics to combat the rise of superbugs. This proposed shift aims to decouple pharmaceutical profits from sales volume, incentivizing R&D in a sector currently plagued by market failure.

3 sources